2.94
+4.26%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Nasus Pharma
Its shares trade under the ticker NSRX. It has been listed since 13 August 2025.
Nasus Pharma Ltd is a IL-based company operating in industry. Nasus Pharma Ltd is an Israel-based pharmaceutical company. The firm conducts ins business activities as a pharmaceutical preparation and intranasal powder-based drug delivery systems manufacturer. Its microsphere technology enables rapid, non-invasive administration of medications for conditions such as anaphylaxis and opioid overdose among others. Nasus Pharma Ltd's formulations are designed for relatively fast absorption, ease of use, and effectiveness in critical situations (such as emergency use). The firm's products predominantly aim to improve access to life-saving treatments by allowing easy administration by caregivers or non-professionals, as well as medical doctors and emergency nurses.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 13 Aug 2025
- Website
- nasuspharma.com ↗
- Head office
- 29 HARAKEVET ST, TEL AVIV - YAFO, L3, 6618003
- Incorporated in
- L3
- Classification
- Pharmaceutical Preparations
- Filer status
- Non-accelerated filer<br>Emerging growth company
Leadership
Pay as last reported
- Mr. Udi GilboaCo-Founder, Executive Chairman of the Board of Director, since 2019
- Mr. Dan TelemanChief Executive Officer
- Dr. Dalia MegiddoCo-Founder, Director, Chief Development Officer and Chief Medical Officer, since 2019
- Mr. Oren ElmaliachDirector of Finance
- Dr. Tair LapidotVice President of Research and Development and Clinical Development
- Dr. Galia KryazDirector of CMC and Product Development
- Mr. Ronnie HershmanIndependent Director
- Mr. Isaac IsraelIndependent Director Nominee
- Dr. Sharon ShachamIndependent Director Nominee
- Mr. David SilbermanIndependent Director Nominee
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Nasus Pharma Ltd is an Israel-based pharmaceutical company with a focus on intranasal powder-based drug delivery systems.
- The company's microsphere technology enables rapid, non-invasive medication administration for critical conditions.
- Products are designed for fast absorption, ease of use, and effectiveness in emergency situations.
Weaknesses
- The company operates in an undefined sector and industry, which may indicate unclear market positioning.
- The firm's business activities are described as a pharmaceutical preparation manufacturer without specific product details.
- No information is provided about the company's financial performance or market share.
Opportunities
- The company's technology could expand access to life-saving treatments for conditions like anaphylaxis and opioid overdose.
- Potential growth in markets requiring non-invasive emergency drug delivery solutions.
- Opportunity to target caregivers and non-professionals for easier medication administration.
Threats
- The company's undefined sector and industry may hinder strategic planning and investor confidence.
- Lack of specific product details could limit market adoption and regulatory approval processes.
- Untrusted source description may lead to inaccurate perceptions of the company's capabilities.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.